Other
Critical Care
0
Pipeline Programs↗
2
Active Trials↗
1
Companies Involved↗
Critical Care is an early-stage landscape with 0 programs across 1 company. The most active players are Institut d'Investigacions Biomèdiques August Pi i Sunyer.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
15
clinical trials
Completed9 · 60%
Unknown status2 · 13%
Terminated1 · 7%
Not yet recruiting1 · 7%
Recruiting1 · 7%
Withdrawn1 · 7%
Clinical Trials
Trial Activity
15 trials
Early Optimization of Ceftazidime Regimen in Critical Care
Not yet recruiting·—·N/A·NCT07085624·128 enrolled
Drug Use Evaluation of Clindamycin in Critical Care Units in Alexandria Main University Hospital
Completed·—·N/A·NCT05223400·99 enrolled
Mean Systemic Filling Pressure Continuous Diuretics Critical Care Patients
Completed·—·N/A·NCT03395951·18 enrolled
Concurrent Subcutaneous Basal Insulin and Intravenous Insulin Pump in Hyperglycemic Crisis Patients Under Critical Care
Unknown status·—·Phase 2·NCT05155917·70 enrolled
Comparison of Clinical Outcome Among Vaccinated and Unvaccinated Coronavirus Disease Patients in Critical Care Unit.
Unknown status·—·N/A·NCT05331742·200 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)